Work

Seroconversion among rituximab-treated patients following SARS-CoV-2 vaccine supplemental dose

Year: 2022

Type: article

Study design: Observational Study

Source: Clinical Immunology

DOI: 10.1016/j.clim.2022.109144

Authors: Emily Rose, Daniel Magliulo, Vasileios C. Kyttaris

Institutions: Beth Israel Deaconess Medical Center, Harvard University

Language: English

Topic: SARS-CoV-2 and COVID-19 Research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4303649353

FWCI: 0.976

Cites: 23

Cited by: 9

Related to: 10